There are many complexities for those designing and reporting cost-effectiveness studies of treatments for MS. Analysts, and ultimately decision makers, face multiple data and methodological challenges. Policy makers, technology developers, clinicians, patients and researchers need to...

The aims of this review were to review decision-analytic models used to evaluate interventions in idiopathic Parkinson's disease (PD), and to consider the future directions for development of methods to model the progression of PD over time. A systematic search of the healthcare literature up to...

The aims of this review were to review decision-analytic models used to evaluate interventions in idiopathic Parkinson’s disease (PD), and to consider the future directions for development of methods to model the progression of PD over time. A systematic search of the healthcare literature up...